-

Medical Devices

  • Share Share this page

February 1997 PMA Approvals

Below are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for February 1997. This list is generated on a monthly basis.

A PDF document that contains the "Approval letter and Summary of Safety and Effectiveness" is being added to this listing for each PMA. The PMA number will appear as a link if this document is available. Information about the PDF Reader is available.

PMA Original Approvals

	

APPLICATION  DEVICE TRADE         COMPANY NAME           DEVICE DESCRIPTION/ 
NUMBER       NAME                 CITY, STATE, & ZIP     INDICATIONS


P930022      MEDTRONIC(r)           MEDTRONIC, INC.         APPROVAL FOR THE
02/07/97     LEGEND PLUSO                                 LEGEND PLUS(r) PACING  
             PULSE GENERATOR      MINNEAPOLIS, MN         SYSTEM INCLUDING THE
                                      55432               LEGEND PLUS(r) PULSE  
                                                          GENERATOR MODELS 8446
                                                          AND 8448; THE MODEL
                                                          9790 AND 9790C
                                                          PROGRAMMERS WITH THE
                                                          MODEL 9891 BASELINE
                                                          SOFTWARE AND WITH THE
                                                          MODE 9807 SOFTWARE.
                                                          THIS SYSTEM IS
                                                          INDICATED FOR
                                                          PERMANENT VENTRICULAR
                                                          OR ATRIAL PACING
                                                          APPLICATIONS.  ITS
                                                          USE IS INDICATED IN
                                                          THE TREATMENT OF
                                                          PATIENTS WHO MAY
                                                          BENEFIT FROM A PACING
                                                          RATE THAT CHANGES IN
                                                          RESPONSE TO ACTIVITY.
                                                          VENTRICULAR 
                                                          INDICATIONS INCLUDE:
                                                          1)CHRONIC ATRIAL
                                                          FLUTTER OR
                                                          FIBRILLATION WITH
                                                          SLOW VENTRICULAR
                                                          RESPONSE; 2)SINUS
                                                          NODE DYSFUNCTIONS OR
                                                          SICK SINUS SYNDROME
                                                          (E.G., SINUS
                                                          BRADYCARDIA, SINUS
                                                          ARREST AND/OR EXIT
                                                          BLOCK,
                                                          BRADYCARDIATACHYCARDIA
                                                          SYNDROME,
                                                          CHRONOTROPIC
                                                          INSUFFICIENCY,
                                                          ETC.,); AND 3)AV
                                                          BLOCK.  ATRIAL
                                                          INDICATIONS
                                                          INCLUDE:1)SINUS NODE
                                                          DYSFUNCTION OR SICK
                                                          SINUS SYNDROME (E.G.,
                                                          SINUS BRADYCARDIA,
                                                          SINUS ARREST AND/OR
                                                          EXIT BLOCK,
                                                          BRADYCARDIATACHYCARDIA
                                                          SYNDROME, ETC.,)
                                                          WITH INTACT AV
                                                          CONDUCTION


APPLICATION  DEVICE TRADE         COMPANY NAME           DEVICE DESCRIPTION/ 
NUMBER       NAME                 CITY, STATE, & ZIP     INDICATIONS


P940014      2-IN-1 DROP          ANGELINI                APPROVAL FOR THE
02/13/97                          PHARMACEUTICALS         2-IN-1 DROP.  THE
                                  CHICAGO, IL             2-IN-1 DROP, PACKAGED
                                      60611               IN THE SINGLE-USE
                                                          CONTAINER, IS
                                                          INDICATED FOR USE
                                                          WITH SOFT
                                                          (HYDROPHILIC) CONTACT
                                                          LENSES (INCLUDING
                                                          DISPOSABLES) AND
                                                          RIGID GAS PERMEABLE
                                                          CONTACT LENSES AS A
                                                          LUBRICATING AND
                                                          REWETTING AGENT
                                                          DURING THE WEARING
                                                          PERIOD AND AS A
                                                          WETTING AGENT TO
                                                          CUSHION LENSES PRIOR
                                                          TO PLACEMENT ON THE
                                                          EYE. THE 2-IN-2 DROP
                                                          MAY ALSO BE USED IN
                                                          PLACE OF A DAILY
                                                          CLEANER AS PART OF AN
                                                          APPROPRIATE CHEMICAL
                                                          DISINFECTION REGIMEN


P960001      DEPUY 1 BONE         DEPUY, INC.             APPROVAL FOR THE
02/11/97     CEMENT                                       DEPUY 1 BONE CEMENT.
                                  WARSAW, IN              THIS DEVICE IS
                                      46581               INDICATED FOR THE
                                                          FIXATION OF
                                                          PROSTHESES TO LIVING
                                                          BONE IN ORTHOPEDIC
                                                          MUSCULOSKELETAL
                                                          SURGICAL PROCEDURES
                                                          FOR RHEUMATOID
                                                          ARTHRITIS,
                                                          OSTEOARTHRITIS,
                                                          TRAUMATIC ARTHRITIS,
                                                          OSTEOPOROSIS,
                                                          AVASCULAR NECROSIS,
                                                          COLLAGEN DISEASE,
                                                          SEVERE JOINT
                                                          DESTRUCTION SECONDARY
                                                          TO TRAUMA OR OTHER
                                                          CONDITIONS AND
                                                          REVISION OF PREVIOUS
                                                          ARTHOROPLASTY.

PMA Supplemental Approvals

APPLICATION  DEVICE TRADE         COMPANY NAME           DEVICE DESCRIPTION/ 
NUMBER       NAME                 CITY, STATE, & ZIP     INDICATIONS


N17908/S047  ALCON SALINE         ALCON LABORATORIES      APPROVAL TO REDUCE
02/10/97     SOLUTION             INC.                    THE MINIMUM GAMMA
                                  FORT WORTH, TX          RADIATION
                                    76134-2099            STERILIZATION DOSE
                                                          SPECIFICATION FROM
                                                          25.0 KGY TO 16.2 KGY
                                                          FOR THE MAJORITY OF
                                                          PRIMARY PACKAGING
                                                          COMPONENTS (BOTTLES,
                                                          PLUGS AND CLOSURES),
                                                          AND FROM 25.0 KGY TO
                                                          18.0 KGY FOR THE 8
                                                          OZ. HIGH DENSITY
                                                          POLYETHYLENE (HDPE)
                                                          BOTTLES AND THE 15
                                                          OZ. LOW DENSITY
                                                          POLYETHYLENE (LDPE)
                                                          BOTTLES.


N18143/S033  FLEX CARE(r)           ALCON LABORATORIES      APPROVAL TO REDUCE
02/10/97     RINSING,             INC.                    THE MINIMUM GAMMA
             DISINFECTING,        FORT WORTH, TX          RADIATION
             AND STORAGE            76134-2099            STERILIZATION DOSE
             SOLUTION                                     SPECIFICATION FROM
                                                          25.0 KGY TO 16.2 KGY
                                                          FOR THE MAJORITY OF
                                                          PRIMARY PACKAGING
                                                          COMPONENTS (BOTTLES,
                                                          PLUGS AND CLOSURES),
                                                          AND FROM 25.0 KGY TO
                                                          18.0 KGY FOR THE 8
                                                          OZ. HIGH DENSITY
                                                          POLYETHYLENE (HDPE)
                                                          BOTTLES AND THE 15
                                                          OZ. LOW DENSITY
                                                          POLYETHYLENE (LDPE)
                                                          BOTTLES.


N50510/S072  VITEK SYSTEMS        BIOMERIEUX VITEK,       APPROVAL FOR CEFEPIME
02/19/97     "GENERAL             INC.                    TO BE INCLUDED ON THE
             SUSCEPTIBILITY       HAZELWOOD, MO           GRAM NEGATIVE
             CARD"                  63042-2395            SUSCEPTIBILITY CARD
                                                          IN THREE
                                                          CONCENTRATIONS
                                                          (EQUIVALENT TO 4, 8
                                                          AND 16æG/ML)


N50510/S073  VITEK SYSTEMS        BIOMERIEUX VITEK,       APPROVAL FOR
02/19/97     "GENERAL             INC.                    CEFPODOXIME TO BE
             SUSCEPTIBILITY       HAZELWOOD, MO           INCLUDED ON THE GRAM
             CARD"                    63042               NEGATIVE
                                                          SUSCEPTIBILITY CARD
                                                          IN THREE
                                                          CONCENTRATION
                                                          (EQUIVALENT TO 1, 2
                                                          AND 4 æG/ML)


APPLICATION  DEVICE TRADE         COMPANY NAME           DEVICE DESCRIPTION/ 
NUMBER       NAME                 CITY, STATE, & ZIP     INDICATIONS


P810046/S169 ACX RX COMET VPO     GUIDANT, CORP.          APPROVAL FOR THE ACS
02/04/97     CORONARY             ACS                     RX COMET VPO   
             DILATATION           TEMECULA, CA            CORONARY DILATATION
             CATHETER               92591-4628            CATHETER. THIS DEVICE
                                                          IS INDICATED FOR
                                                          BALLOON DILATATION OF
                                                          THE STENOTIC PORTION
                                                          OF A CORONARY ARTERY
                                                          OR BYPASS GRAFT
                                                          STENOSIS FOR THE
                                                          PURPOSE OF IMPROVING
                                                          MYOCARDIAL PERFUSION.


P820001/S020 OPTI-FREE(r)           ALCON LABORATORIES      APPROVAL TO REDUCE
02/10/97     SUPRACLENSO DAILY    INC.                    THE MINIMUM GAMMA
             PROTEIN REMOVER      FORT WORTH, TX          RADIATION
                                    76134-2099            STERILIZATION DOSE 
                                                          SPECIFICATION FROM
                                                          25.0 KGY TO 16.2 KGY
                                                          FOR THE MAJORITY OF
                                                          PRIMARY PACKAGING
                                                          COMPONENTS (BOTTLES,
                                                          PLUGS AND CLOSURES), 
                                                          AND FROM 25.0 KGY TO
                                                          18.0 KGY FOR THE 8
                                                          OZ. HIGH DENSITY
                                                          POLYETHYLENE
                                                          (HDPE)BOTTLES AND THE
                                                          15 OZ. LOW DENSITY
                                                          POLYETHYLENE LDPE)
                                                          BOTTLES.


P820053/S025 COMFORCARE GP(r)       ALLERGAN                APPROVAL FOR
02/13/97     WETTING AND SOAKING                          ALLERGAN, 8301 MARS
             SOLUTION             IRVINE, CA              DR., WACO, TX 76712
                                    92623-9534            AS AN ALTERNATE
                                                          MANUFACTURING SITE


P830034/S030 OPTI-CLEAN(r) II       ALCON LABORATORIES      APPROVAL TO REDUCE
02/10/97       DAILY CLEANER      INC.                    THE MINIMUM GAMMA
             OPTI-FREE(r) DAILY     FORT WORTH, TX          RADIATION
               CLEANER              76134-2099            STERILIZATION DOSE
             OPTI-FREE(r) EXPRESS                           SPECIFICATION FROM
               MULTI-PURPOSE                              25.0 KGY TO 16.2 KGY
               SOLUTION                                   FOR THE MAJORITY OF
             OPTI-FREE(r) REWETTING                         PRIMARY PACKAGING
               DROPS                                      COMPONENTS (BOTTLES,
             OPTI-FREE(r) RINSING,                          PLUGS AND CLOSURES),
               DISINFECTING, AND                          AND FROM 25.0 KGY TO
               STORAGE SOLUTION                           18.0 KGY FOR THE 8
             OPTI-ONEO MULTI-                             OZ. HIGH DENSITY
               PURPOSE SOLUTION                           POLYETHYLENE (HDPE)
             OPTI-ONEO REWETTING                          BOTTLES AND THE 15
               DROPS                                      OZ. LOW DENSITY
             OPTI-SOAKO DAILY                             POLYETHYLENE (LDPE)
               CLEANER                                    BOTTLES.
             OPTI-SOAKO SOOTHING
               DROPS
             OPTI-SOFT(r) SOLUTION
             OPTI-TEARS(r) SOOTHING
               DROPS
        



APPLICATION  DEVICE TRADE         COMPANY NAME           DEVICE DESCRIPTION/ 
NUMBER       NAME                 CITY, STATE, & ZIP     INDICATIONS


P830071/S007 OPTI-SOAKO           ALCON LABORATORIES      APPROVAL TO REDUCE
02/10/97     CONDITIONING         INC.                    THE MINIMUM GAMMA
             SOLUTION WETTING,    FORT WORTH, TX          RADIATION
             SOAKING,               76134-2099            STERILIZATION DOSE 
             CONDITIONING, AND                            SPECIFICATION FROM
             DISINFECTING                                 25.0 KGY TO 16.2 KGY
             SOLUTION ID 84392                            FOR THE MAJORITY OF
                                                          PRIMARY PACKAGING
                                                          COMPONENTS (BOTTLES,
                                                          PLUGS AND CLOSURES),
                                                          AND FROM 25.0 KGY TO
                                                          18.0 KGY FOR THE 8
                                                          OZ. HIGH DENSITY
                                                          POLYETHYLENE (HDPE)
                                                          BOTTLES AND THE 15
                                                          OZ. LOW DENSITY
                                                          POLYETHYLENE (LDPE)
                                                          BOTTLES.


P840001/S039 ITREL II SPINAL      MEDTRONIC               APPROVAL FOR A
02/28/97     CORD STIMULATION     NEUROLOGICAL            Y-EXTENSION (MODEL
             SYSTEM, INCLUDING    MINNEAPOLIS, MN         7498) AND Y-SCREENING
             A BIFURCATED           55440-9087            CABLE (MODEL 3552).
             Y-EXTENSION


P840068/S032 DELTA(r) PACEMAKER     CARDIAC                 APPROVAL FOR THE
02/18/97     SYSTEM (VIGOR SSI    PACEMAKERS (CPI)        MODIFICATION OF THE
             AND DDD MODELS       ST. PAUL, MN            DIAGNOSTIC
             ONLY)                  55112                 (SELF-TEST) FUNCTION
                                                          OF THE MODEL 2909
                                                          MULTIPLE APPLICATION
                                                          UTILITY (MAU) TO
                                                          ACCOMMODATE
                                                          VARIABILITY IN WATCH
                                                          DOG TIMER (WDT)
                                                          TIME-OUT PERIODS.


P850062/S002 ABBOTT ANTI-DELTA    ABBOTT LABORATORIES     CHANGE IN THE
02/26/97     EIA                                          SPECIFICATIONS FOR
                                  ABBOTT PARK NORTH, IL   THE CONJUGATE
                                    60064-3500            CONCENTRATE FROM A
                                                          NEGATIVE CONTROL
                                                          SAMPLE WITH A
                                                          STANDARD RATIO OF
                                                          0.90- 1.10, TO A
                                                          NEGATIVE CONTROL MEAN
                                                          O.D. OF 1.17 - 1.43.




APPLICATION  DEVICE TRADE         COMPANY NAME           DEVICE DESCRIPTION/ 
NUMBER       NAME                 CITY, STATE, & ZIP     INDICATIONS


P850089/S036 CAPSURE(r) AND         MEDTRONIC, INC.         APPROVAL FOR
02/04/97     CAPSURE(r) SP                                  DISTRIBUTION BY
             SILICONE PACING      MINNEAPOLIS, MN         VIATRON, INC. OF THE
             LEADS                  55432-3576            MODELS CAPSURE(r) Z,  
                                                          5033, 5934, 5534 AND
                                                          CAPSUREFIX(r)  4068
                                                          UNDER A NEW TRADE
                                                          NAME. THE DEVICES
                                                          WILL BE MARKETED
                                                          UNDER THE TRADE NAMES
                                                          VITATRON(r)  
                                                          IMPULSE(O IMG 49,  
                                                          IMPULSEO IMG 49B,
                                                          IMPULSEO IMG 49JB,
                                                          AND PIROUETO+IMU
                                                          49B, AND ARE
                                                          INDICATED FOR CHRONIC
                                                          PACING AND SENSING OF
                                                          THE ATRIUM AND/OR
                                                          VENTRICLE.


P880003/S064 TITAN MEGA  AND      CORDIS, CORP.           APPROVAL FOR TITAN
02/10/97     TITAN MEGA XL                                MEGA AND TITAN MEGA
             PTCA DILATATION      MIAMI LAKES, FL         XL PTCA DILATATION
             CATHETERS              33102-5700            CATHETERS. THESE
                                                          CATHETERS ARE
                                                          INDICATED FOR BALLOON
                                                          DILATATION OF THE
                                                          STENOTIC PORTION OF
                                                          A CORONARY ARTERY OR
                                                          BYPASS GRAFT STENOSIS
                                                          FOR THE PURPOSE OF
                                                          IMPROVING MYOCARDIAL
                                                          PERFUSION.


P880027/S042 SCHNEIDER CHUBBYO    SCHNEIDER (USA),        ADDITIONAL BALLOON
02/04/97     PTCA CATHETERS       INC.                    SIZES OF 4.5 AND 5.0
                                  MINNEAPOLIS, MN         MM IN THE CHUBBY PTCA
                                    55442                 CATHETER LINE.


P880027/S043 ASUKAO AND           SCHNEIDER (USA),        INCREASE IN RATED
02/19/97     ASUKAO LONGY         INC.                    BURST PRESSURE FOR
             PTCA CATHETERS       MINNEAPOLIS, MN         THE SCHNEIDER
                                    55442                 ASUKAO AND
                                                          ASUKAO LONGY PTCA
                                                          CATHETERS.


P880027/S044 GOLDIEO AND         SCHNEIDER (USA), INC.    INCREASE IN RATED
02/19/97     GOLDIEO LONGY                                BURST PRESSURE FOR
             PTCA CATHETERS       MINNEAPOLIS, MN         THE GOLDIEO AND   
                                    55442                 GOLDIEO LONGY PTCA
                                                          CATHETERS.


P880062/S002 SONOTHERM 1000       LABTHERMICS             APPROVAL FOR CHANGES
02/13/97     ULTRASOUND           TECHNOLOGIES, INC.      TO THE COMPUTER
             HYPERTHERMIA         CHAMPAIGN, IL           SYSTEM AND REVISIONS
             SYSTEM                 61820                 TO THE OPERATOR'S
                                                          MANUAL FOR THE
                                                          SONOTHERM 1000.



APPLICATION  DEVICE TRADE         COMPANY NAME           DEVICE DESCRIPTION/ 
NUMBER       NAME                 CITY, STATE, & ZIP     INDICATIONS


P890048/S006 USCI(r)                USCI DIVISION           MODIFIED LABELING FOR
02/04/97     PROBE IIIO           C.R. BARD, INC.         USCI(r) PROBE IIIO   
             BALLOON-ON-A-        BILLERICA, MA           BALLOON-ON-A-WIREO   
             WIREO                    01821               DILATATION SYSTEM.
             DILATATION
             SYSTEM


P890055/S002 MODEL 3000           ARROW, INTL.            APPROVAL FOR (1) A
02/04/97     CONSTANT FLOW                                CHANGE IN LABELING
             IMPLANTABLE          WALPOLE, MA             FOR THE MODEL 3000
             INFUSION PUMP          02081                 CONSTANT FLOW
             WITH BOLUS                                   IMPLANTABLE INFUSION
             SAFETY VALVE                                 PUMP WITH BOLUS
                                                          SAFETY VALVE TO
                                                          INCLUDE AN INDICATION
                                                          FOR THE INTRASPINAL
                                                          DELIVERY OF
                                                          PRESERVATIVE-FREE
                                                          MORPHINE SULFATE FOR
                                                          THE TREATMENT OF PAIN
                                                          OF MALIGNANT ORIGIN
                                                          AND (2) THE
                                                          INTRASPINAL CATHETER
                                                          KIT.


P900056/S018 ROTABLATOR(r)          BOSTON SCIENTIFIC       APPROVAL FOR THE
02/13/97     ROTATIONAL           CORP.                   ROTALINKO   
             ANGIOPLASTY          REDMOND, WA             EXCHANGEABLE CATHETER
             SYSTEM WITH THE        98052-3376            FOR THE ROTABLATOR(r)  
             ROTALINKO                                    ROTATIONAL
                                                          ANGIOPLASTY SYSTEM
                                                          AND IS INDICATED FOR
                                                          USE IN PATIENTS WITH
                                                          CORONARY ARTERY
                                                          DISEASE WHO ARE
                                                          CANDIDATES FOR
                                                          CORONARY ARTERY
                                                          BYPASS GRAFT (CABG)
                                                          SURGERY AND WHO MEET
                                                          ONE OF THE FOLLOWING
                                                          CRITERIA:SINGLE
                                                          VESSEL
                                                          ATHEROSCLEROTIC
                                                          CORONARY ARTERY
                                                          DISEASE WITH A
                                                          STENOSIS THAT CAN BE
                                                          PASSED WITH A GUIDE
                                                          WIRE; MULTIPLE VESSEL
                                                          CORONARY ARTERY
                                                          DISEASE THAT IN THE
                                                          PHYSICIAN'S JUDGMENT
                                                          DOES NOT POSE UNDO
                                                          RISK TO THE PATIENT;
                                                          CERTAIN PATIENTS WITH
                                                          PREVIOUS PTCA, AND
                                                          WHO HAVE A RESTENOSIS
                                                          OF THE NATIVE VESSEL;
                                                          OR NATIVE VESSEL
                                                          ATHEROSCLEROTIC
                                                          CORONARY ARTERY
                                                          DISEASE THAT IS LESS
                                                          THAN 25 MM IN LENGTH.



APPLICATION  DEVICE TRADE         COMPANY NAME           DEVICE DESCRIPTION/ 
NUMBER       NAME                 CITY, STATE, & ZIP     INDICATIONS


P900061/S021 MEDTRONIC(r) MODELS    MEDTRONIC, INC.         APPROVAL FOR
02/04/97     7219B/C/D/E AND                              ALTERNATE
             7202C/D/E            MINNEAPOLIS, MN         FIRMWARE/HARDWARE
                                    55432-3576            DESIGN FOR THE
                                                          MEDTRONIC(r) MODELS   
                                                          7219B/C/D/E AND
                                                          7202C/D/E


P910020/S017 MARATHON Z PULSE     SULZER INTERMEDICS      APPROVAL FOR
02/10/97     GENERATOR MODELS     INC.                    MODIFICATIONS TO THE
             294-09Z AND          ANGLETON, TX            MARATHON DR AND SR
             292-09Z;                 77515               PULSE GENERATORS,
             MOMENTUM DR PULSE                            GRAPHICS PROGRAM
             GENERATOR MODELS                             MODULE MODEL 570-01,
             294-23, 294-23Z,                             AND TO THE RELEASE
             AND 293-23;                                  2.00 SOFTWARE FOR USE
             GRAPHICS PROGRAM                             WITH THE RX5000
             MODULE MODEL                                 GRAPHICS PROGRAMMER.
             570-01; AND                                  THE DEVICE, AS
             RELEASE 2.02                                 MODIFIED, WILL BE
             SOFTWARE WITH USE                            MARKETED UNDER THE
             WITH RX5000 GRAPHICS                         TRADE NAMES MARATHON
             PROGRAMMER                                   Z PULSE GENERATOR
                                                          MODELS 294-09Z AND
                                                          292-09Z, MOMENTUM DR
                                                          PULSE GENERATOR
                                                          MODELS 294-23,
                                                          294-23Z, AND 292-23,
                                                          GRAPHICS PROGRAM
                                                          MODULE MODEL 570-01,
                                                          AND RELEASE 2.02
                                                          SOFTWARE WITH USE
                                                          WITH RX5000 GRAPHICS
                                                          PROGRAMMER, AND IS
                                                          INDICATED FOR LONG
                                                          TERM CARDIAC PACING


P910031/S012 ARCO BALLOON         CARDIOVASCULAR          APPROVAL FOR THE
02/27/97     CORNARY              DYNAMICS, INC.          ADDITION OF THE 2.0
             DILATATION           IRVINE, CA              MM BALLON SIZE TO THE
             CATHETERS              92618                 ARCO BALLOON
                                                          CORONARY DILATATION
                                                          CATHETERS


P910067/S001 SVS APEX PLUS        SUMMIT TECHNOLOGY,      APPROVAL FOR THE SVS
02/07/97     EXCIMER LASER        INC.                    APEX PLUS EXCIMER
             SYSTEM FOR           WALTHAM, MA             LASER SYSTEM.
             PHOTOTHERAPEUTIC       02154
             KERATECTOMY (PTK)
             AND PHOTOREFRACTIVE
             KERATECTOMY (PRK)


P910077/S020 VENTAK(r) PRX AICD     CARDIAC PACEMAKERS      APPROVAL FOR THE
02/18/97     SYSTEM               (CPI)                   MODIFICATION OF THE
                                  ST. PAUL, MN            DIAGNOSTIC
                                    55112-5798            (SELF-TEST) FUNCTION
                                                          OF THE MODEL 2909
                                                          MULTIPLE APPLICATION
                                                          UTILITY (MAU) TO
                                                          ACCOMMODATE
                                                          VARIABILITY IN WATCH
                                                          DOG TIMER (WDT)
                                                          TIME-OUT PERIODS.

APPLICATION  DEVICE TRADE         COMPANY NAME           DEVICE DESCRIPTION/ 
NUMBER       NAME                 CITY, STATE, & ZIP     INDICATIONS


P930034/S001 SVS APEX             SUMMIT TECHNOLOGY,      APPROVAL TO USE LASER
02/05/97     (FORMERLY            INC.                    VISION CORRECTION OR
             OMNIMED) EXCIMER     WALTHAM, MA             LVC AS A SYNONYM FOR
             LASER SYSTEM FOR       02154                 PHOTOREFRACTIVE
             PHOTOREFRACTIVE                              KERATECTOMY OR PRK IN
             KERATECTOMY (PRK)                            YOUR LABELING.  THE
                                                          APPLICATION IS
                                                          APPROVED SUBJECT TO
                                                          THE CONDITION THAT
                                                          LVC WILL NOT BE USED
                                                          IN THE FOLLOWING
                                                          INSTANCES: 1)IN ADS
                                                          TO PRACTITIONERS;
                                                          2)IN SECTION THAT
                                                          CONTAIN THE APPROVED
                                                          INDICATION,
                                                          CONTRAINDICATION,
                                                          WARNING, PRECAUTION,
                                                          CAUTION, AND "A-J"
                                                          STATEMENTS IN THE FDA
                                                          APPROVAL ORDER DATED
                                                          OCTOBER 20, 1995; 3)
                                                          ON THE TITLE PAGE OF
                                                          THE PATIENT
                                                          INFORMATION BOOKLET;
                                                          4) AT THE BEGINNING
                                                          OF TEXT IN A BOOKLET
                                                          OR AN AD, UNTIL THE
                                                          TERM "LASER VISION
                                                          CORRECTION (LVC)" IS
                                                          DEFINED AS A
                                                          REPLACEMENT FOR PRK;
                                                          AND 5) WHEN
                                                          DISTINGUISHING THE
                                                          VARIOUS SURGERIES,
                                                          E.G., PTK AND PRK
                                                          (NOT LVC).


P930034/S002 SVS APEX PLUS        SUMMIT TECHNOLOGY,      APPROVAL FOR THE SVS
02/07/97     EXCIMER LASER        INC.                    APEX PLUS EXCIMER
             SYSTEM FOR           WALTHAM, MA             LASER SYSTEM.
             PHOTOTHERAPEUTIC       02154
             KERATECTOMY (PTK)
             AND PHOTOREFRACTIVE
             KERATECTOMY (PRK)




APPLICATION  DEVICE TRADE         COMPANY NAME           DEVICE DESCRIPTION/ 
NUMBER       NAME                 CITY, STATE, & ZIP     INDICATIONS


P930039/S003 CAPSUREFIX(r) MODEL    MEDTRONIC, INC.         APPROVAL FOR
02/04/97     4068 PACING LEAD                             DISTRIBUTION BY
                                  MINNEAPOLIS, MN         VIATRON, INC. OF THE
                                    55432-3576            MODELS CAPSURE((r) Z, 
                                                          5033, 5034, 5534 AND
                                                          CAPSUREFIX(r) 4068  
                                                          UNDER A NEW TRADE
                                                          NAME.  THE DEVICES
                                                          WILL BE MARKETED
                                                          UNDER THE TRADE NAMES
                                                          VITATRON(r)  
                                                          IMPULSEO IMG 49,   
                                                          IMPULSEO IMG 49B,   
                                                          IMPULSEO IMG 49JB,   
                                                          AND PIROUETO+IMU   
                                                          49B, AND ARE
                                                          INDICATED FOR CHRONIC
                                                          PACING AND SENSING OF
                                                          THE ATRIUM AND/OR
                                                          VENTRICLE.


P940008/S004 RES-QO MICRON        SULZER INTERMEDICS      APPROVAL FOR A NEW
02/28/97     ICD SYSTEM           INC.                    IMPLANTABLE
                                  ANGLETON, TX            CARDIOVERTER
                                    77515                 DEFIBRILLATOR (ICD)
                                                          SYSTEM.  THE DEVICE,
                                                          AS MODIFIED, WILL BE
                                                          MARKETED UNDER THE
                                                          TRADE NAME RES-QO   
                                                          MICRON MODEL 101-09
                                                          AND MODEL 101-05


P940031/S009 VIGOR(r) DR/SR         CARDIAC PACEMAKERS      APPROVAL FOR THE
02/18/97     PACEMAKER SYSTEM     (CPI)                   MODIFICATION OF THE
                                  ST. PAUL, MN            DIAGNOSTIC
                                      55112               (SELF-TEST) FUNCTION
                                                          OF THE MODEL 2909
                                                          MULTIPLE APPLICATION
                                                          UTILITY (MAU) TO
                                                          ACCOMMODATE
                                                          VARIABILITY IN WATCH
                                                          DOG TIMER (WDT)
                                                          TIME-OUT PERIODS.


P950039/S002 THINPREP(r)            CYTYC, CORP.            APPROVAL FOR THE USE
02/25/97     2000 SYSTEM                                  OF THE COMBINATION OF
                                  BOXBOROUGH, MA          ENDOCERVICAL BRUSH
                                    01719                 AND PLASTIC SPATULA
                                                          AS AN ALTERNATIVE TO 
                                                          THE BROOM-TYPE
                                                          SAMPLING DEVICE FOR
                                                          THE THINPREP(r) 2000
                                                          SYSTEM


P950040/S001 DR. BROWN'S HOME     PERSONAL HEALTH &       APPROVAL FOR A
02/26/97     DRUG TESTING SYSTEM  HYGIENE, INC.           VOLUNTARY PLEDGE AND
                                  BALTIMORE, MD           CONSENT FORM AS PART
                                    21204                 OF THE LABELING





APPLICATION  DEVICE TRADE         COMPANY NAME           DEVICE DESCRIPTION/ 
NUMBER       NAME                 CITY, STATE, & ZIP     INDICATIONS

P950040/S002 DR. BROWN'S HOME     PERSONAL HEALTH &      APPROVAL FOR:
02/05/97     DRUG TESTING KIT     HYGIENE, INC.          CHANGING THE TESTING
                                  BALTIMORE, MD          LABORATORY TO
                                    21204                AMERICAN MEDICAL
                                                         LABORATORY (AML);
                                                         INCLUDING HEROIN
                                                         TESTING AS PART OF
                                                         THE TEST SYSTEM; AND
                                                         REVISED LABELING IN
                                                         ASSOCIATION WITH THE
                                                         ADDED HEROIN TESTING.


ERRATA
ORIGINAL APPROVAL OMITTED FROM OCTOBER 1996 MONTHLY APPROVAL REPORT

P920031      EMIT(r) 2000           BEHRING                INDICATED FOR IN
10/02/96     CYCLOSPORINE         DIAGNOSTICS, INC.      VITRO DIAGNOSTIC
             SPECIFIC ASSAY       SAN JOSE, CA           USE ON THE ROCHE
                                    95161-9013           DIAGNOSTICS SYSTEMS 
                                                         COBAS MIRA, COBAS
                                                         MIRA S, AND COBAS
                                                         MIRA PLUS CHEMISTRY
                                                         SYSTEMS FOR THE 
                                                         QUANTITATIVE ANALYSIS
                                                         OF CYCLOSPORINE (CsA)
                                                         IN HUMAN WHOLE BLOOD
                                                         AS AN AID IN THE 
                                                         MANAGEMENT OF
                                                         CYCLOSPORINE THERAPY
                                                         IN KIDNEY, HEART,
                                                         AND LIVER TRANSPLANT
                                                         PATIENTS

                                    
    
-
-
-
-
-